106 related articles for article (PubMed ID: 7690952)
1. Comparative analysis of the expression of tenascin and established prognostic factors in human breast cancer.
Moch H; Torhorst J; Dürmüller U; Feichter GE; Sauter G; Gudat F
Pathol Res Pract; 1993 Jun; 189(5):510-4. PubMed ID: 7690952
[TBL] [Abstract][Full Text] [Related]
2. Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.
Howeedy AA; Virtanen I; Laitinen L; Gould NS; Koukoulis GK; Gould VE
Lab Invest; 1990 Dec; 63(6):798-806. PubMed ID: 1701508
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
4. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining patterns of tenascin in invasive breast carcinomas.
Shoji T; Kamiya T; Tsubura A; Hatano T; Sakakura T; Yamamoto M; Morii S
Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):53-6. PubMed ID: 1378984
[TBL] [Abstract][Full Text] [Related]
6. Expression of tenascin in human cervical cancer--association of tenascin expression with clinicopathological parameters.
Pilch H; Schäffer U; Schlenger K; Lautz A; Tanner B; Höckel M; Knapstein PG
Gynecol Oncol; 1999 Jun; 73(3):415-21. PubMed ID: 10366470
[TBL] [Abstract][Full Text] [Related]
7. Alteration of stromal protein and integrin expression in breast--a marker of premalignant change?
Jones JL; Critchley DR; Walker RA
J Pathol; 1992 Aug; 167(4):399-406. PubMed ID: 1383484
[TBL] [Abstract][Full Text] [Related]
8. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
9. Tenascin staining positivity and the survival of patients with invasive breast carcinoma.
Shoji T; Kamiya T; Tsubura A; Hamada Y; Hatano T; Hioki K; Morii S
J Surg Res; 1993 Sep; 55(3):295-7. PubMed ID: 7692137
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cells are an important source of tenascin in normal and malignant human breast tissue.
Lightner VA; Marks JR; McCachren SS
Exp Cell Res; 1994 Feb; 210(2):177-84. PubMed ID: 7507849
[TBL] [Abstract][Full Text] [Related]
11. Tenascin expression in normal and abnormal human endometrium.
Sasano H; Nagura H; Watanabe K; Ito K; Tsuiki A; Sato S; Yajima A; Kusakabe M; Sakakura T
Mod Pathol; 1993 May; 6(3):323-6. PubMed ID: 7688462
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of an extracellular matrix protein, tenascin and breast diseases].
Ishihara A; Yatani R; Sakakura T
Rinsho Byori; 1993 Oct; 41(10):1099-107. PubMed ID: 7504753
[TBL] [Abstract][Full Text] [Related]
13. Tenascin in reactive lymph nodes and in malignant lymphomas.
Soini Y; Alavaikko M; Lehto VP; Virtanen I
Pathol Res Pract; 1992 Dec; 188(8):1078-82. PubMed ID: 1284450
[TBL] [Abstract][Full Text] [Related]
14. Tenascin patterns of expression in duct carcinoma in situ of the breast.
Iskaros BE; Sison CP; Hajdu SI
Ann Clin Lab Sci; 2000 Jul; 30(3):266-71. PubMed ID: 10945566
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of tenascin in normal human salivary glands and in pleomorphic adenomas.
Sunardhi-Widyaputra S; Van Damme B
Pathol Res Pract; 1993 Mar; 189(2):138-43. PubMed ID: 7686669
[TBL] [Abstract][Full Text] [Related]
16. [Tenascin-C expression in human breast tumors].
Tökés AM; Kulka J
Orv Hetil; 2003 Sep; 144(39):1901-7. PubMed ID: 14598568
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the patterns of laminin expression in fibroadenoma, fibrocystic diseases, pre-invasive and invasive ductal breast carcinoma.
Zheng WQ; Looi LM; Cheah PL
Pathology; 2001 Aug; 33(3):303-6. PubMed ID: 11523929
[TBL] [Abstract][Full Text] [Related]
18. [Expression of extracellular matrix (tenascin) in the gastric cancer--an immunohistochemical study].
Yano S
Nihon Geka Gakkai Zasshi; 1993 Oct; 94(10):1085-91. PubMed ID: 7694065
[TBL] [Abstract][Full Text] [Related]
19. Can tenascin be redundant in cancer development?
Sakakura T; Kusakabe M
Perspect Dev Neurobiol; 1994; 2(1):111-16. PubMed ID: 7530137
[TBL] [Abstract][Full Text] [Related]
20. [Detection of tenascin in stomach cancer. An immunohistochemical study].
Broll R; Kayser K; Vollmer G; Plagemann M; Bruch HP
Zentralbl Pathol; 1994 Jul; 140(2):123-8. PubMed ID: 7524650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]